kol call today et discuss result strh
dial
strh biotech team host investor call two
key opinion leader discuss result survey
recent conduct postpartum depress
therapeut buy complet submiss
nda fda brexanolon treatment moder
sever postpartum depress believ would
ideal time take deep dive diagnosi current treatment
new therapi compar nbi index
share friday like due fade
hope deal buy yatin suneja
ioni nr neurolog diseas well
news chairman kevin starr sold share last
week opinion howev believ fundament
chang invest thesi would continu
strong buyer current level
dr kristina deligiannidi md director women
behavior zucker hillsid hospit associ
professor center psychiatr neurosci
feinstein institut medic research dr deligiannidi also
associ professor psychiatri obstetr gynecolog
donald barbara zucker school medicin hofstra/
northwel provid consult short-term treatment
women suffer depress anxieti pregnanc
post-partum period expertis focus
psychopharmacolog complementary/altern treatment
depress anxieti peri-partum period includ
lactat dr kristina deligiannidi serv clinic investig
brexanolon current run trial
author numer public
paid consult dr kristina deligiannidi receiv
medic degre complet psychiatri resid
chief resid psychopharmacolog research univers
massachusett medic school
dr deligiannidi join faculti zucker hillsid hospital/
feinstein institut medic research/hofstra northwel school
medicin septemb board certifi
american board psychiatri neurolog
dr jason jame md board certifi obstetrician-gynecologist
privat practic miami area sinc
current chief obstetr gynecolog baptist hospit
dr jame receiv medic degre univers
miami complet resid obstetr gynecolog
midstream oil ga midstream thought gray oak barrel
andeavor buckey
us major gsk read-across
 advair gener price pressur
kol call et discuss result strh
long island jewish medic center dr jame receiv
numer award includ patient choic recognit
award everi year sinc well name one
best physician consum guid top physician
addit dr jame also recogn america top ob/
gyn receiv compassion doctor recognit
outstand dedic patient special interest
postpartum depress name acog issu
year research award recipi
take shape new ceo take rein
compstore ep beat encourag expect investor
confid build special investor call
new ceo brian niccol lay specif plan drive
sale strengthen oper mr niccol valu brand
posit food integr believ much
better job market expect increas focu exist
sale driver like digit order pickup deliveri cater
new sale driver like well test menu innov
extend hour maintain buy increas pt
buy anoth top-to-bottom beat importantli
gener net book bill lead
y/i backlog growth quarter strength core
cro busi appear bolster solid show
symphoni provid addit upsid lever
see strength side busi give us
confid manag re-affirmed guidanc believ
continu demonstr doubl digit top-lin growth
least two larg strateg partnership
continu ramp pt model review sandi
impella case mix adjust reimburs histori
propos inpati rule suggest around step-down
averag reimburs fy rel fy propos
reimburs level still significantli superior
seen fy fy show strong impella
growth continu believ use remain overwhelmingli
appropri mere seek align reimburs
underli patient severity/cost bruce nudel
 met sever denver base compani
matt lepor former cogcc director came away
better understand polit regulatori midstream
environ wattenberg polit regulatori chang
credibl risk basin howev would argu
alreadi embed lower multipl like threat
weld counti drill ga take-away remain topic
mewbourn plant come compani
page
hump growth plan thu low
multipl seen achiev well fitzpatrick
take shape new ceo take rein
compstore ep beat encourag expect investor
confid build special investor call
new ceo brian niccol lay specif plan drive
sale strengthen oper mr niccol valu brand
posit food integr believ much
better job market expect increas focu exist
sale driver like digit order pickup deliveri cater
new sale driver like well test menu innov
extend hour maintain buy increas pt
gate strong rais est maintain pt
rais ebitda follow strong
expect better attendance/pr dynam
increment int licens incom pt reflect
lower ep follow challeng
believ could slower-growth dynam
next year expens pleas
share buy-back announc flag emerg market
growth less compel stori limit quarter-to-quart
visibl keep us sidelin maintain pt
lodg overal revpar y/i week
end per str prior week result
stack revpar vs
prior week independ hotel data set
y/i upper upscal strongest chain
scale brand hotel economi weakest
midscal upper midscal under-perform
overal us hotel industri averag within upper upscal
stronger transient vs prior week
 met sever denver base compani
matt lepor former cogcc director came away
better understand polit regulatori midstream
environ wattenberg polit regulatori chang
credibl risk basin howev would argu
page
alreadi embed lower multipl like threat
weld counti drill ga take-away remain topic
mewbourn plant come compani
hump growth plan thu low
multipl seen achiev well fitzpatrick
estim price lower estim price target
maintain buy gener strong
return capit cash flow lower growth
expect account real world structur friction
indic pressur pump price stabl sinc
spate earli price cut competitor util
hamper custom delay slow start januari
although appear improv slowli labor suppli
chain constraint lead complet delay gap
frac calendar expect slower product growth ken
sign recoveri progress evid better expect
oper result confid sale
middl east rig take place next month given
wft comment price longer negoti
implic view deal close
regulatori legal paperwork hoop jump
requir complet partial sale busi
span multipl countri middl east part
world patienc requir maintain buy rate price
expect across board ken sill
littl oper updat attach in-lin quarter well
 estim chang storag week
end bcf withdraw pink dot graph
median bloomberg estim bcf estim
primarili driven respect week weather hdd/
cdd look back histor last year saw bcf
inject hdd/cdd five year averag
bcf inject hdd/cdd pleas see graph
sweet spot highli variabl region believ
question decreas eur well under-perform
earn plagu midcon group ytd
average ytd vs xop answer
upcom call though type curv lower
particularli stack understand wide variabl
rock within scoop merg stack stark differ
seen one posit next
page
street midcon prod estim could slightli high variou
compani given time nfx remain one favorit
play longer term basi neal dingmann
gain strong cwc drop deconsolid well
 view today eia neutral crude energi
stock build crude gasolin inventori off-set draw
distil total crude primari inventori
modest mmbbl miss consensu estim
mmbbl draw week total inventori build posit
season basi mmbbl less averag build
week net import fell third week row
driven higher product export note refineri util fell
bp second week row ken sill
midstream oil ga tristan richardson
favor benefit deal volum despit
competit lend environ although higher lt rate
put pressur valuat bdc mostli floating-r
loan portfolio benefit higher short term rate along
abil increas leverag could long-term
catalyst favorit bdc stage arcc cct
tslx combin portfolio transform
anomali maintain buy option maintain
buy rate revis ep estim
reflect downsid lower
spread revenu price target
previous view higher nco anomali
buy rate long-term orient base pb
rel profit expens control credit conservat
larg secur book pb beneficiari
steepen yield curv addit see option pb
opportunist acquir seller jennif demba
inc buy upsid featur
better top-line reserv gain mark hugh
upsid reserv gain current year loss mark
page
restructur stori strong deposit franchis
support out-performance maintain buy rate
pt ep ep estim
lower reflect credit
driven ep miss expect consensu ep move higher
reflect benefit deliv excel initi
believ like year program could incorpor
addit benefit beyond expens reduct
emerg restructur stori target roe
top third peer group franchis signific cost
reduct opportun sticki core deposit franchis
markel corpor hold lower
loss rais estim follow earn releas
confer call rais ep estim
driven out-performance
well reduc loss assumpt come quarter
boost estim compani
post solid underwrit result though flow-through book
valu off-set fx movement volatil equiti
portfolio reiter price target repres
bvp in-lin peer believ compani
buy anoth top-to-bottom beat importantli
gener net book bill lead
y/i backlog growth quarter strength core
cro busi appear bolster solid show
symphoni provid addit upsid lever
see strength side busi give us
confid manag re-affirmed guidanc believ
continu demonstr doubl digit top-lin growth
least two larg strateg partnership
continu ramp pt model review sandi
impella case mix adjust reimburs histori
propos inpati rule suggest around step-down
averag reimburs fy rel fy propos
reimburs level still significantli superior
seen fy fy show strong impella
growth continu believ use remain overwhelmingli
appropri mere seek align reimburs
underli patient severity/cost bruce nudel
laboratori corpor america hold lh
remain bullish lh follow superb result mark brisk
page
divis solid cash flow despit headwind
weather pama addit lh continu make tangibl
progress consum engag combin
strength highli complementari busi line
increasingli reson see signific increment growth
head room reiter buy pt
inc buy particip two
aesthet confer week particip
two aesthet confer nyc week aesthet
apr view grow presenc industri forum
increas awar gain kol mindshar aesthet
neurotoxin market clinic de-risk asset
interchang efficaci market leader botox catalyst
fda eir releas base case assumpt fda
push pdufa month end summer
launch risk/reward attract reiter
ep support dcf analysi john bori
channel share access/reimburs medicare/
beat street mrk zostavax sale
project declin vs street viiv
hiv sale miss street vs report fx
demand read-out mrk isentress
pressur sale declin vs
street advair us price pressur
 myl launch novartis/hikma delay
 john bori
therapeut file nda brexanolon
treatment moder sever postpartum depress
thought would ideal time take in-depth
look target prescrib treat current
clinic outcom see current
standard care believ result
survey compris psychiatrist obstetrician bode well
strong brexanolon uptak approv edward nash
clarif last night tavr number bruce nudel
show compel profil mg yesterday
meet argx present full phase ii data
antibodi fragment target fcrn myasthenia
page
gravi data compar favor soliri trial
convincingli demonstr treatment lead
rapid long-last improv key efficaci measur
mg-adl qmg maintain good safeti profil
discuss regul on-going phase design
remain track begin later year near-term stock
move catalyst includ top-line pv itp aug/
top-lin margin growth stori intact rais
adjust ep estim
estim maintain price
target reflect target multipl
ebitda estim respect histor averag
forward multipl one deviat
usg corpor usg hold margin take hit
expect result weak outstand offer
knauf privat manag comment
call littl impact stock volum
cost hurt result wallboard price show nice sequenti
gain degrad modest sequenti could show
notabl year year gain ceil volum
also posit easi comp pre-buy upcom
investor vote director challeng knauf remain
key factor stock remain hold believ slightli
elev bid may eventu agre keith hugh
inc buy gate
strong reiter buy rate rais pt
reiter buy rate rais pt
post beat/lift qtr pleasant surpris
strong organ revenue growth yoy margin expans
oper metric may deterior vs
growth temper tougher comp howev
new management team still process instal new strategic/
oper plan believ oper improv
upsid materi progress believ may
investor day catalyst continu rank
favorit idea michael ciarmoli
margin oc stock fell releas
cost pressur weigh result particularli roof
insul price record second strong sequenti
page
quarter bright spot result believ
look volatil strong insul price continu
similar contribut margin roof price
attempt push move margin oc
valuat attract view short-term
roll buy exit confer confid
continu strong top-lin growth margin expans
impress free cash flow convers
revenu vs year ago increas ep estim
slightli
number current human capit group
leader solid hold maintain hold pt
quarter driven continu new custom momentum
said view balanc risk/reward consid l-
competit threat guard view toward pay
venmo monet new rev/ebitda est
prior
street
visa inc buy perk buy reiter
buy pt ebitda adjust
rev/ebitda est
prior
street
opinion core growth hold deserv premium
payment stock reflect co lead global
share expand valu proposit ecosystem central
may grow revenue quickli pure-play e-commerce
processor believ visa long-term organ revenue
prospect inher superior andrew jeffrey
growth buy reiter buy temper pt
ebitda reflect conserv
macro view ebitda estim materi unchang
contend euronet multipl way maintain
organ revenue growth irrespect dcc extern risk
bullish strong global remitt growth increasingli
fuel indian share gain digit channel eft
nascent move merchant acquir new market bank
page
partnership deal fast indian growth mute dcc risk
creat long runway above-avg revenue growth view
goal buy reiter buy rate pt base
robust organ growth bp oper
margin expans evid success integr
acquisit close confid meet
exceed adj ebitda goal gener
organ top-lin growth adj ebitda ep estim
start year ssnoi declin ki bin
inc hold result guidanc
miss higher revenu especi expens
elus find bottom ki bin
result chang guidanc portfolio metric remain
leas activ lead guidanc increas ki bin
game leisur properti inc buy in-
line print surpris pnk escal boost guidanc slightli
 updat estim affo/shar goe
affo/shar goe
model assum pnk hold build rent
escal effect model includ pend
deal match guidanc estim deal could
accret affo/shar depend financ detail
price target goe lower multipl
expect continu accret deal opportun patrick
 rais ffo estim reflect
beat though lower pt
incorpor higher treasury/discount rate dcf
page
calcul increas cap rate analysi
assum persist discount
next month bigger pictur continu like
pipelin strong low-lev balanc sheet forecast
competit growth stock trade below-averag
ffo multipl unusu deep discount michael
realti trust inc buy set stage
cleaner stori reiter buy ad
report result larg ahead expect
believ first clean quarter recent
unexpected/underwhelm surpris larg
attribut compani reorgan busi
expect momentum continu indic pipelin
commentari increas focu hyperscal realign
sale team current expect impli stock
overli bearish view recommend investor buy
favor risk/reward greg miller
 guidanc detail confound question
answer post solid oper result
outlook howev manag defer answer import
question till analyst day linear datacent ramp
 size crypto zte impact sell-in rev-rec
transit confound model ultim see much
 upsid owe mil demand great fit
bullish thesi server acceler ep goe
ep goe premium
fade moder target price-to-earnings pt goe
facebook inc fb buy strong resili face
controversi maintain buy except maintain
buy rate rais pt result
strong show impact user growth/engag
despit recent controversi data privaci also revis
guidanc opex capital-expenditure fund increas security/
content invest better fear gdpr effect
tighter data rule us algo chang priorit
qualiti content/interact still expect deceler user/
engag growth lower margin chang
lead cleaner engag platform consum
ultim market youssef squali
page
ebay inc buy slow/steadi progress
buy follow broadli in-lin reiter outlook
sign gradual progress turnaround user growth
eas somewhat expect see pickup come
qtr driven brand advertis effort increas audienc
exposur new product experi use structur data
plan move intermedi payment remain
track address gmv migrat
compel valuat signific cash strong
remain author buy-back keep us
posit name youssef squali
expect result like pressur stock tomorrow greg
 comcast report mix solid result view
better-than-expect nbcu make mix cabl result
former continu benefit success multi-
year turnaround effort latter contend secular headwind
pay-tv separ manag made unsolicit
bid sky-lon nr offici begin process
sharehold regulatori approv thesi littl chang
believ share remain attract given cmcsa lead
broadband content asset level better price
risk relat maintain buy greg miller
post acceler sale growth continu outstand
execut stay hold valuat yet deliv
solid beat conserv guidanc guidanc
consensu best-in-class oper
stay hold owe valuat ep goe
ep goe
pt remain base price-to-earnings premium
peer appli ep estim william stein
pressur outlook hold maintain hold rate
lower pt follow mix result
outlook revis downward compani top advertis
partner larg ota rais roi threshold
like put pressur commerci manag
continu make progress improv qualiti lead
partner ultim help drive sustain growth
busi lack clariti time turnaround well
nt hit partner roi chang keep us sidelin
cautiou outlook/valu keep us hold twtr strong
page
beat acceler revenu growth show platform
reson market world-wide improv monet
particularli intern main driver rather user
growth momentum like sustain management
outlook seem reflect slowdown driven part uncertainti
around data protect polici especi gdpr europ
view continu improv acceler growth
better cost contain lead record margin
valuat keep us sidelin pt goe
sink margin expect recoveri next year hold
subcom help past hurt right
investor long memori recal subcom prevent
tel breach coven back credit crisi today
subcom drag margin organ ep expect
recoveri next year overal estim go higher strength
area defens industri equip fx tax
ep goe ep goe
pt goe base
ep in-line william stein
internet read trvg
 view trvg hold result announc morn
management commentari posit increment read result
report neutral report
neg read report trvg largest ad partner
larg ota appear rais roi threshold recent
view posit ad effici put
page
may seacoast bank corp florida ndr ceo cfo kc mid-west
may ndr cfo svp financ canada new
may travelport world-wide ltd tvpt ndr evp/cfo head ir new york boston
may manag meet american ga associ aga confer phoenix
may manag meet intern council shop center icsc confer hf cushman wakefield
may ndr head ir new york
june inc group dinner chairmn ceo cfo chairman carolinas/virginia evp carolinas/virginia
page
june dowdupont inc dwdp ndr director ir director ir kc mid-west new
june inc ndr cfo vice-president ir mid-west canada new
june nareit meet host suntrust robinson humphrey new york
may edward nash peter lawson yatin suneja mid-west
page
april estimate conf call crm/mule investor call suntrust svp enterpris solut deliveri manag
page
issu research report suntrust robinson humphrey inc analyst name report herebi certifi
recommend opinion express accur reflect research analyst person view
subject secur compani discuss herein part research analyst compens directli
indirectli relat specif recommend view express report
